Alpha Crest Capital Management LLC Axsome Therapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $226,024 - $437,819	6,268 New	6,268 $280,000
Q2 2020 Aug 12, 2020	SELL	$49.87 - $98.69 $189,506 - $375,022	-3,800 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $156,560 - $384,978	3,800 New	3,800 $224,000

327

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.